Fu and colleagues demonstrated that TG2 inhibition with monodansylcadaverine (MDC) suppresses cell proliferation and induces apoptosis in CD44+ glioma stem cells through the decrease of inhibitor of DNA binding 1 protein (ID1) and that this, therefore, may be a TG2 downstream regulator [98]. The gene discussed is CD44; the disease is central nervous system cancer.